Purchase Order 75N91019P00695

<p>The National Institute on Aging awarded a purchase order to Peprotech Inc. for $9,470.00 on August 8, 2017, with completion by September 7, 2017. Performance occurs in Baltimore, Maryland. The order procures cytokine and protein products for research use under firm fixed-price terms with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on September 5, 2018, with an ultimate completion date of October 5, 2018. Performance occurs in Bethesda, Maryland. The order is a firm fixed price purchase of molecular biology products, reagents, and research supplies. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

This is a $7,215 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Peprotech Inc. on May 18, 2012. The contract is for the delivery of biological and reagent materials such as recombinant human growth factors and cytokines to support NIAID's research efforts. Peprotech Inc. is a privately-owned biotechnology company that develops and manufactures cytokine products....

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,666.96 on June 28, 2017. Performance occurs in Piscataway, New Jersey. The order procures peptide services on a firm fixed price basis, with ultimate completion targeted for July 27, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,633.62 on August 22, 2017. The order is for peptide services and carries no set-aside designation. Work is performed in Piscataway, New Jersey. The purchase order is firm fixed price and concludes September 30, 2017.</p>